Non-Hodgkin’s lymphoma of nasopharynx diagnosed during pregnancy (a case from practice) by Kitsera, N. et al.
110 Experimental Oncology 33, 110–111, 2011 (June)
NON-HODGKIN’S LYMPHOMA OF NASOPHARYNX DIAGNOSED 
DURING PREGNANCY (A CASE FROM PRACTICE)
N. Kitsera1, N. Helner1, O. Kitsera2, Z. Osadchuk1
1Institute of Hereditary Pathology of National Academy of Medical Sciences of Ukraine, Lviv, Ukraine
2 Danylo Halytsky National Medical University, Lviv, Ukraine
The article presents the case of 32 years old woman with non-Hodgkin’s lymphoma of the nasopharynx who received the antican-
cer treatment at 21-26 weeks of pregnancy (20 courses of radiation in dose of 40 Gy on the right half of the nasopharynx). The 
pregnancy was performed by cesarean section at the term of 32 weeks, and a healthy girl was born. Timely diagnosis and correct 
treatment of non-Hodgkin’s lymphoma give the woman a chance to have a healthy child.
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Cancer is the second leading cause of death 
in women of reproductive age. The most common 
tumors diagnosed during pregnancy are breast and 
cervical cancer, Hodgkin’s lymphoma and non-Hodg-
kin’s lymphoma, leukemias, and malignant melanoma. 
The aim of therapy in pregnancy is to give optimal treat-
ment to a mother without harm to a fetus. In the first 
trimester organogenesis continues, so chemotherapy 
should not be given because of increasing risk of spon-
taneous abortion, fetal malformation, and mortality. 
One of important and actual problems of modern 
oncology and hematology is diagnostics and treat-
ment of non-Hodgkin’s lymphoma [1, 2]. Frequency 
of non-Hodgkin’s lymphoma is constantly increasing 
both in Ukraine and in the world. From the data of Na-
tional Cancer-Register Bulletin of Ukraine an amount 
of the first registered cases of non-Hodgkin’s lym-
phomas in 2008 year was 2088. An index of morbid-
ity on 100 thousands of population is 4.4, among 
women — 3.6, among men — 5.4. Lethality of primary 
patients with non-Hodgkin’s lymphomas in Ukraine 
is 36.5% during one year. In 30–35 % of patients the 
primary standard treatment results in the progress-
ing or relapse of the disease. The index of five-year 
survival in the group of patients does not exceed 
30–40%. Thus, the problem of diagnostics and 
treatment of non-Hodgkin’s lymphomas is of high 
actuality [3].
Also, practical gynecologists have the certain warn-
ings concerning the conduct of pregnancy and births 
in women with oncopathology in anamnesis, especially 
if this pathology is diagnosed during pregnancy [4–6]. 
Most of women with such diagnosis do not risk to plan 
a pregnancy, because they are afraid to give a sick 
child and don’t know where to receive a qualified help.
In this case report, we have retrospectively 
analyzed  a case of a patient with non-Hodgkin’s lym-
phoma of nasopharynx that was diagnosed during 
pregnancy and who received anticancer treatment 
during pregnancy.
The patient O.P., 32 years of old, was under a su-
pervision in woman’s consultation at the home clinic 
concerning the first pregnancy. She was complaining 
a bed nasal breathing, obstruction of the nose, short 
breathing, headache, which was not controlled under 
the standard methods of treatment. After consultation 
the non-Hodgkin’s lymphoma of nasopharynx was 
diagnosed.
The patient appealed to the medical genetic center 
of Institute of Hereditary Pathology (Lviv, Ukraine) for 
determination of possible risk for birth defects and ab-
normalities of her child, as far as the malignant tumor 
was diagnosed during pregnancy and she disagreed 
on terminating pregnancy.
During the genealogical examination it has been 
found that her paternal uncle died from the cancer 
of digestive system at the age of 50. Husband’s aunt 
died at age of 70 from cancer of inner organs. Birth 
defects, abnormalities, childless marriages, abortions, 
stillbirth were not discovered in this family tree. The 
woman wanted to save pregnancy and to have a child, 
so she was looking for support and help in different 
state and private clinics.
At the comprehensive assessment of pregnant 
woman somatic pathology was not found, only in-
creased post-neck lymphatic nodules from both sides 
(0.2–0.4 cm).
Computer tomography from 29.12.2009 has 
revealed the picture of volume process of right half 
of nasal cavity with distribution to the right wall of naso-
pharynx. It needed differentiation between tumor and 
polyposis. While at the beginning of observation blast 
cells were not found, but complaint increased and the 
clinical state got worse; so other researches were done. 
Immunological research, conducted on 14.01.2010, 
did not find signs of clonal proliferation of cells. Mor-
phological research from 20.01.2010 of  bone marrow 
discovered 21–23% lymphocytes, blast cells were 
not found. Pathoanatomical conclusion of trepana-
tion of iliac bone from 27.01.2010 revealed the focal 
affection of marrow diagnosed as at a large cell lym-
phoma. The analysis of blood from 25.01.2010, done 
in a term of 16–17 weeks of  pregnancy, demonstrated 
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only the high indexes of ESR — 42 mm per hour, and 
insignificant decrease of hemoglobin — 105 g/L. Other 
blood indexes and coagulogram were normal. During 
ultrasound examination from 03.02.2010 what corre-
sponded to 18 weeks of pregnancy, no pathologies and 
abnormalities of fetus organs and placenta were found. 
Only an uterus was in hypertonus. During the dynamic 
ultrasound examinations no pathology of fetus, and 
fetometric data according to the term of gestation were 
found. The repeated computer tomography of brain 
from 25.02.2010 found the signs of tumor of right half 
of nasal cavity with dissemination in ethmoidal, sphe-
noid and maxillary sinuses at the same side. 
Conclusion of internal pathology specialists: 
17 weeks pregnancy, a non-Hodgkin’s lymphoma 
of right half of nasal cavity. A patient was informed 
about the risk of birth defects, malformations, lack 
of amniotic fluid and possible antenatal death of fetus.
Taking into account woman’s categorical refusal 
of medical abortion, the tactic of treatment was lim-
ited to the tele-gamma-therapy at the maintenance 
of pregnancy. On the patient’s consent the treatment 
was conducted from 01.03.2010 to 10.04.2010 during 
21–26 weeks of pregnancy (20 courses of irradiation 
in a dose 40 Grey on the right half of nasal cavity). The 
patient listened to the advices of doctors, which took 
into account all risks (mutagenic, teratogenic, and 
also carcinogenic effects on a fetus), and the chances 
of successful completion of pregnancy, that support 
her faith and her hope to born a healthy child. After 
termination of tele-gamma-therapy, relapse of tumor 
was not found. 
The conclusion of oncologists from 20.04.2010 was: 
a non-Hodgkin’s lymphoma of nasal cavity grade ІІ, 
state after a tele-gamma-therapy, 28 weeks of preg-
nancy. They recommended the woman to prolong the 
treatment after delivery. 
As the clinical manifestation of non-Hodgkin’s lym-
phoma of nasal cavity was revealed in the ІІ trimester 
of pregnancy, a risk of the teratogenic effect is low 
(1–2%). The conducted tele-gamma-therapy during 
pregnancy (21–26 week) promotes the risk of new 
mutations, particularly in the somatic cells of fetus 
to 1–2%, and also an appearance of dysmorphic minor 
birth anomalies. The pregnant woman was informed 
about possible carcinogenic effect on fetus (1–2%), 
and also the risk of low birth weight, decreased im-
munity of child and perinatal losses with recognition 
of general population risk — 5%. The total risk of birth 
defects and hereditary pathology in this situation was 
8–11%. The decision of woman was to prolong preg-
nancy and to give birth to a child. 
At the term of 32 weeks of pregnancy (18.05.2010) 
by Caesar section the healthy girl was born with the 
weight of 2040 g, height of 45 cm, by 7 points of Apgar. 
The newborn was diagnosed with anaemia of I-st de-
gree (109 g/L).
Regardless on heavy oncological pathology, 
the patient felt normal after delivery. The woman 
began the course of chemotherapy (mabtera, cy-
clophosphamide, doxorubicin, vincristine) in July, 
2010 —1.5 months after delivery, and continues the 
treatment. Undesirable effect of treatment was alo-
pecia, diarrhea, enhanceable nervousness.
01.10.2010 at the  age of 4.5 months, the 
child’s weighs was 6 kg, haemoglobin was 150 g/L. Af-
ter the chil’s examination, a conclusion of pediatrician, 
neurologist, haematologist and other specialists was 
“clinically healthy, physical growth corresponds to the 
age”.
This case from practice, about the non-Hodg-
kin’s lymphoma of nasal cavity in pregnant woman and 
its correct treatment during pregnancy, has showed 
how to overcome acute flow of illness, to born a healthy 
child, and continue treatment after delivery, when 
a patient is positively adjusted by doctor’s and family 
support [7–8]. The close collaboration of gynecolo-
gists, oncologists, geneticists and doctors of other 
specialities, the selection of correct treatment modality 
of cancer during pregnancy reduce the risks of compli-
cations and delivery and give woman a chance to born 
a healthy child.
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